Clinical Trials Directory

Trials / Completed

CompletedNCT05219474

A Computational Approach to Optimal Deactivation of Cochlear Implant Electrodes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

The goal of the present study is to use computationally driven models of speech understanding in cochlear implant (CI) users to guide the search for which combination of active electrodes can yield the best speech understanding for a specific patient. It is hypothesized that model-recommended settings will result in significantly better speech understanding than standard-of-care settings.

Detailed description

Aim 1 is to quantify speech understanding and sound quality with model-recommended combinations of active electrodes compared to standard settings, and compared to two control active electrode combinations. Aim 2 is to translate the model-driven recommendations from Aim 1 into practical guidance about how many (and possibly which) CI electrodes to deactivate.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCochlear implant Computer Model ImplementationThe computer model will use standard Cochlear Implant settings to evaluate psychophysical and speech understanding abilities and sound quality with standard CI settings and then use these measures to build subject-specific models and determine experimental active electrode conditions to be tested: model-optimized, and two best-electrodes settings (2 types); 3) evaluate speech understanding and sound quality measures after using experimental settings regularly for 1.5 months; and 4) compare performance across experimental and clinical conditions. The analysis will include four levels of repeated measures with active CI electrode conditions. These levels include the clinical baseline condition (all available electrodes active) and three experimental conditions (model-optimized, best-electrodes, and restricted best-electrodes).

Timeline

Start date
2022-05-01
Primary completion
2025-04-30
Completion
2025-04-30
First posted
2022-02-02
Last updated
2025-10-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05219474. Inclusion in this directory is not an endorsement.